C Partners Holding Gmb H Bristol Myers Squibb CO Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $96,398 - $125,005	-1,977 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $123,846 - $139,689	-2,244 Reduced 53.16%	1,977 $123,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $33,450 - $41,692	662 Added 18.6%	4,221 $234,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $41,764 - $48,079	-697 Reduced 16.38%	3,559 $225,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $255,104 - $278,129	4,256	4,256 $261,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $112B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.